BEECHAM UNIT LAUNCHES ARTHRITIS DRUG LONDON MARCH 2 BEECHAM GROUP PLC  BHAML SAID ITS SUBSIDIARY  BEECHAM PHARMACEUTICALS LAUNCHED A NEW ONCE A DAY PRESCRIPTION ONLY MEDICINE FOR THE REDUCTION OF PAIN AND INFLAMMATION CAUSED BY RHEUMATOID AND OSTEOARTHRITIS THE LAUNCH TOOK PLACE SIMULTANEOUSLY IN THE UK AND WEST GERMANY THE DRUG WHICH HAS THE APPROVED NAME NABUMETONE WILL BE INTRODUCED TO DOCTORS IN THE UK UNDER THE BRAND NAME OF RELIFEX AND WILL BE KNOWN AS ARTHAXAN IN WEST GERMANY   